Abaris Biotechnology Opportunities A CHF

Abaris Biotechnology Opportunities focuses on growing investors' capital by investing primarily in global companies within the biotechnology, pharmaceuticals, biosciences, and healthcare sectors. The fund selects a diverse range of individual stocks and equity-like securities, including American Depositary Receipts (ADRs) and Chinese H-shares traded in Hong Kong dollars. It has the flexibility to concentrate up to 100% of its investments in these areas while also maintaining a portion of its assets in liquid cash or similar investments to adapt to changing market conditions. This strategic approach allows the fund to capitalize on advancements and opportunities in the life sciences and healthcare industries worldwide.